6 completed, 1 terminated. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 6, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Shingles: new trials by email Literature Review of Shingles trials Research Report on Shingles
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia FV-100, valacyclovir - Shingles, Herpes Zoster | Phase 3 | Terminated | ContraVir Pharmaceuticals, Inc. | 237 | 2015-06-01 | 2017-12-22 |
| Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025) Zoster Vaccine Live - Herpes Zoster, Shingles | Phase 3 | Completed | Merck Sharp & Dohme LLC | 250 | 2012-10-31 | 2018-09-18 |
| Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1) Zoster Vaccine, Live (AMP), Zoster Vaccine, Live - Herpes Zoster, Shingles | Phase 3 | Completed | Merck Sharp & Dohme LLC | 498 | 2012-04-01 | 2017-04-12 |
| Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022) Zoster Vaccine, Live (Zostavax™), Comparator: Placebo - Shingles | Phase 3 | Completed | Merck Sharp & Dohme LLC | 22439 | 2007-10-01 | 2017-04-12 |
| Study of NGX-4010 for the Treatment of Postherpetic Neuralgia NGX-4010 - Peripheral Nervous System Diseases, Pain | Phase 3 | Completed | NeurogesX | 400 | 2006-03-01 | 2008-03-06 |
| Study of NGX-4010 for the Treatment of Postherpetic Neuralgia NGX-4010 - Peripheral Nervous System Diseases, Pain | Phase 3 | Completed | NeurogesX | 400 | 2005-06-01 | 2008-03-06 |
| NGX-4010 for the Treatment of Postherpetic Neuralgia Capsaicin Dermal Patch - Herpes Zoster, Neuralgia | Phase 2 / Phase 3 | Completed | NeurogesX | 300 | 2008-03-06 |
Herpes Zoster (7) · Neuralgia (3) · Neuralgia, Postherpetic (3) · Pain (3) · Peripheral Nervous System Diseases (3)
DNA Virus Infections (7) · Herpesviridae Infections (7) · Infections (7) · Varicella Zoster Virus Infection (7) · Virus Diseases (7) · Nervous System Diseases (4) · Neurologic Manifestations (4) · Neuromuscular Diseases (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Neuralgia (1) · Pain (1) · Peripheral Nervous System Diseases (1)
Herpes Zoster Vaccine (3) · Capsaicin (2) · Adenosine Monophosphate (1) · FV-100 (1) · Valacyclovir (1)
Merck Sharp & Dohme LLC (3) · NeurogesX (3) · ContraVir Pharmaceuticals, Inc. (1)
United States (2)
Jeffrey Tobias, MD (2) · John Sullivan-Bolyai (1)
PMID 18977178, PMID 21087403, PMID 22291101, PMID 23908486, PMID 24823623, PMID 31325263, PMID 37781954